Fig. 3
From: Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis
UCB-Exo reduce histological injuries and improve liver function in mice with CCl4-induced liver fibrosis. Schematic diagram of liver fibrosis. Mice were administered CCl4 for 1 month (n = 20) and divided into two groups, namely, a CCl4 group (CCl4 + PBS), and an UCB-Exo group (CCl4 + UCB-Exo for 2 months) (A). Liver sections were stained with H&E and are shown in (B). Scale bar: 100 μm. Serum AST (C) and ALT (D) levels were analyzed. Data are presented as the mean ± SEM. ***p < 0.001